AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| BCT | CommSec Executive Series Interview With Andrew McLellan | 24/04/18 | ||
| BCT | Appendix 4C - quarterly | PRICE SENSITIVE | 23/04/18 | |
| BCT | Presentation to Goldman Sachs Small & Midcap Conference | 17/04/18 | ||
| BCT | Corporate Overview and March 2018 Update | PRICE SENSITIVE | 14/03/18 | |
| BCT | Open Briefing - 1H FY18 results and outlook | PRICE SENSITIVE | 27/02/18 | |
| BCT | Half Yearly Report and Accounts | PRICE SENSITIVE | 26/02/18 | |
| BCT CommSec Executive Series Interview With Andrew McLellan | |||
| 24/04/18 | |||
| BCT Appendix 4C - quarterly | |||
| 23/04/18 | PRICE SENSITIVE | ||
| BCT Presentation to Goldman Sachs Small & Midcap Conference | |||
| 17/04/18 | |||
| BCT Corporate Overview and March 2018 Update | |||
| 14/03/18 | PRICE SENSITIVE | ||
| BCT Open Briefing - 1H FY18 results and outlook | |||
| 27/02/18 | PRICE SENSITIVE | ||
| BCT Half Yearly Report and Accounts | |||
| 26/02/18 | PRICE SENSITIVE | ||
